VEGFR Targeting Leads to Significantly Enhanced Tumor Uptake of Nanographene Oxide in Vivo

Biomaterials - United Kingdom
doi 10.1016/j.biomaterials.2014.10.061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Enhanced Expression of FHL2 Leads to Abnormal Myelopoiesis in Vivo

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Imaging Cytokine Targeting to the Tumor/Bone MicroenvironmentIn Vivo

Human gene therapy. Clinical development
Genetics
2014English

Antibody-Mediated Targeting of Iron Oxide Nanoparticles to the Folate Receptor Alpha Increases Tumor Cell Association in Vitro and in Vivo

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2015English

Cooled Radiofrequency Ablation Produces Enhanced Thermal Lesions and Leads to Beneficial Neuroadaptions in Vivo

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Metal‐Supported Solid Oxide Electrolysis Cell (MS‐SOEC) With Significantly Enhanced Catalysis

Energy Technology
Energy
2019English

Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting

Journal of Drug Delivery
2013English

Electrographic Seizures Are Significantly Reduced by in Vivo Inhibition of Neuronal Uptake of Extracellular Glutamine in Rat Hippocampus

Epilepsy Research
Neurology
2013English

The Deficiency of Galectin-3 in Stromal Cells Leads to Enhanced Tumor Growth and Bone Marrow Metastasis

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy